Compile Data Set for Download or QSAR
Found 239 with Last Name = 'tarpley' and Initial = 'wg'
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM554(5-cyano-N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-ph...)
Affinity DataKi:  0.00700nM ΔG°:  -63.0kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM558(N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.00800nM ΔG°:  -62.7kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM557(N-{3-[(1R)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.0180nM ΔG°:  -60.7kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM560(N-{3-[(1S)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.0320nM ΔG°:  -59.3kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM553(5-cyano-N-{3-[(1R)-1-[(6S)-4-hydroxy-2-oxo-6-(2-ph...)
Affinity DataKi:  0.0400nM ΔG°:  -58.8kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM550(N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.0600nM ΔG°:  -57.8kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM556(5-cyano-N-{3-[(1S)-1-[(6R)-4-hydroxy-2-oxo-6-(2-ph...)
Affinity DataKi:  0.100nM ΔG°:  -56.5kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM555(5-cyano-N-{3-[(1S)-1-[(6S)-4-hydroxy-2-oxo-6-(2-ph...)
Affinity DataKi:  0.120nM ΔG°:  -56.1kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM549(N-{3-[(1R)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.120nM ΔG°:  -56.1kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM559(N-{3-[(1S)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.220nM ΔG°:  -54.6kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM552(N-{3-[(1S)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  0.300nM ΔG°:  -53.8kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM551(N-{3-[(1S)-1-[(6S)-4-hydroxy-2-oxo-6-(2-phenylethy...)
Affinity DataKi:  1nM ΔG°:  -50.9kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM548(CHEMBL21188 | N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenyl...)
Affinity DataKi:  1nM ΔG°:  -50.9kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50212827(CHEMBL3350189)
Affinity DataKi: <1nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50229416(CHEMBL3350192)
Affinity DataKi:  2nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM547(CHEMBL20846 | N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenyl...)
Affinity DataKi:  3nM ΔG°:  -48.2kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046938(CHEMBL366392 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  4nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50229415(CHEMBL3350190)
Affinity DataKi:  4nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50000696(CHEMBL301833)
Affinity DataKi:  5nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046922(CHEMBL428804 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  5nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046932(CHEMBL173255 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  5nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50368288(CHEMBL1790564 | CHEMBL3350194)
Affinity DataKi:  5nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50000794(CHEMBL299376)
Affinity DataKi:  5nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM546(4-fluoro-N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl...)
Affinity DataKi:  6nM ΔG°:  -46.5kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50000758(CHEMBL48770)
Affinity DataKi:  7nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM545(4-cyano-N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl)...)
Affinity DataKi:  8nM ΔG°:  -45.7kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046940(CHEMBL176353 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  8nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046941(CHEMBL175393 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  10nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50229414(CHEMBL3350191)
Affinity DataKi:  11nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50229413(CHEMBL3350218)
Affinity DataKi:  12nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046920(CHEMBL172927 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  16nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM544(N-(3-{1-[4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propy...)
Affinity DataKi:  17nM ΔG°:  -43.9kJ/molepH: 5.0 T: 2°CAssay Description:HIV-1 protease was purified and refolded from E. coli inclusion bodies. The substrate used spans the p17-p24 processing site (R-V-S-Q-N-Y-P-I-V-Q-N-K...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50368830(CHEMBL1790518)
Affinity DataKi:  22nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50453058(CHEMBL3085447)
Affinity DataKi:  22nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50000732(CHEMBL432309)
Affinity DataKi:  26nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50368283(CHEMBL1790565 | CHEMBL3350195)
Affinity DataKi:  28nMAssay Description:Inhibitory activity against HIV-1 proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50368829(CHEMBL1790517)
Affinity DataKi:  36nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046929(CHEMBL369428 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  48nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046934(CHEMBL174307 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  100nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046921(CHEMBL176737 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  100nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046935(CHEMBL367066 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  140nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046939(CHEMBL367712 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi: >200nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046923(CHEMBL173652 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi: >200nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046933(CHEMBL176674 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi: >200nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046936(CHEMBL355806 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi: >200nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046924(CHEMBL366531 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  200nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046927(CHEMBL355815 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi:  200nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046925(CHEMBL367637 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi: >200nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046928(CHEMBL176613 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi: >200nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Upjohn Company

Curated by ChEMBL
LigandPNGBDBM50046931(CHEMBL176840 | N-(4-{1-[(1H-Benzoimidazol-2-ylmeth...)
Affinity DataKi: >200nMAssay Description:Inhibition of HIV-1 protease in vitro.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 239 total ) | Next | Last >>
Jump to: